[
  {
    "id": "fc_abg_46bc936e",
    "front": "PET/CT: ALK inhibitor progression detection?",
    "back": "Detects progression earlier than CT in nearly half of events.",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Arterial Blood Gas Interpretation",
    "bookId": "abg",
    "sourceSection": "PART 3 – Clinical Respiratory Medicine",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_17_OCR",
      "chapter": "**Pulmonary Edema**",
      "section": "PART 3 – Clinical Respiratory Medicine",
      "pageNumber": 31
    }
  },
  {
    "id": "fc_abg_bebc0a6d",
    "front": "Thoracoscopy yield: malignant pleural effusion?",
    "back": "95% (vs. cytology 62%, closed biopsy 44%).",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Arterial Blood Gas Interpretation",
    "bookId": "abg",
    "sourceSection": "PART 3 – Clinical Respiratory Medicine",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_17_OCR",
      "chapter": "**Pulmonary Edema**",
      "section": "PART 3 – Clinical Respiratory Medicine",
      "pageNumber": 31
    }
  },
  {
    "id": "fc_abg_1bdd56fa",
    "front": "TSC2 deficiency: immunotherapy response?",
    "back": "Responds to anti-PD-1/anti-CTLA-4 therapy.",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Arterial Blood Gas Interpretation",
    "bookId": "abg",
    "sourceSection": "PART 3 – Clinical Respiratory Medicine",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_17_OCR",
      "chapter": "**Pulmonary Edema**",
      "section": "PART 3 – Clinical Respiratory Medicine",
      "pageNumber": 31
    }
  },
  {
    "id": "fc_abg_2a2c4082",
    "front": "LAM: Upregulated immune checkpoint?",
    "back": "PD-L1.",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Arterial Blood Gas Interpretation",
    "bookId": "abg",
    "sourceSection": "PART 3 – Clinical Respiratory Medicine",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_17_OCR",
      "chapter": "**Pulmonary Edema**",
      "section": "PART 3 – Clinical Respiratory Medicine",
      "pageNumber": 31
    }
  },
  {
    "id": "fc_abg_dd563032",
    "front": "TSC1/TSC2: effect on mTOR?",
    "back": "Inhibit mTORC1 activation (via Rheb).",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Arterial Blood Gas Interpretation",
    "bookId": "abg",
    "sourceSection": "PART 3 – Clinical Respiratory Medicine",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_17_OCR",
      "chapter": "**Pulmonary Edema**",
      "section": "PART 3 – Clinical Respiratory Medicine",
      "pageNumber": 31
    }
  },
  {
    "id": "fc_abg_cb9294b3",
    "front": "Temsirolimus: mechanism of action?",
    "back": "mTOR inhibitor.",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Arterial Blood Gas Interpretation",
    "bookId": "abg",
    "sourceSection": "PART 3 – Clinical Respiratory Medicine",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_17_OCR",
      "chapter": "**Pulmonary Edema**",
      "section": "PART 3 – Clinical Respiratory Medicine",
      "pageNumber": 31
    }
  },
  {
    "id": "fc_abg_bbe6477d",
    "front": "TSC2 deficiency activates which pathway?",
    "back": "mTORC1 signaling pathway.",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Arterial Blood Gas Interpretation",
    "bookId": "abg",
    "sourceSection": "PART 3 – Clinical Respiratory Medicine",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_17_OCR",
      "chapter": "**Pulmonary Edema**",
      "section": "PART 3 – Clinical Respiratory Medicine",
      "pageNumber": 31
    }
  },
  {
    "id": "fc_abg_266fd925",
    "front": "TSC2-deficient tumors respond to?",
    "back": "Anti-PD-1/anti-CTLA-4 immunotherapy.",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Arterial Blood Gas Interpretation",
    "bookId": "abg",
    "sourceSection": "PART 3 – Clinical Respiratory Medicine",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_17_OCR",
      "chapter": "**Pulmonary Edema**",
      "section": "PART 3 – Clinical Respiratory Medicine",
      "pageNumber": 31
    }
  },
  {
    "id": "fc_abg_926924a6",
    "front": "PD-L1 expression in pulmonary LAM?",
    "back": "Upregulated.",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Arterial Blood Gas Interpretation",
    "bookId": "abg",
    "sourceSection": "PART 3 – Clinical Respiratory Medicine",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_17_OCR",
      "chapter": "**Pulmonary Edema**",
      "section": "PART 3 – Clinical Respiratory Medicine",
      "pageNumber": 31
    }
  },
  {
    "id": "fc_abg_5b547b35",
    "front": "Sporadic pulmonary LAM caused by?",
    "back": "Mutations in TSC2 gene.",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Arterial Blood Gas Interpretation",
    "bookId": "abg",
    "sourceSection": "PART 3 – Clinical Respiratory Medicine",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_17_OCR",
      "chapter": "**Pulmonary Edema**",
      "section": "PART 3 – Clinical Respiratory Medicine",
      "pageNumber": 31
    }
  },
  {
    "id": "fc_abg_bea21066",
    "front": "TSC1/TSC2 inhibit what protein/pathway?",
    "back": "Rheb, antagonize mTOR signaling.",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Arterial Blood Gas Interpretation",
    "bookId": "abg",
    "sourceSection": "PART 3 – Clinical Respiratory Medicine",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_17_OCR",
      "chapter": "**Pulmonary Edema**",
      "section": "PART 3 – Clinical Respiratory Medicine",
      "pageNumber": 31
    }
  },
  {
    "id": "fc_abg_d3e6ca9a",
    "front": "Temsirolimus mechanism of action?",
    "back": "mTOR inhibitor.",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Arterial Blood Gas Interpretation",
    "bookId": "abg",
    "sourceSection": "PART 3 – Clinical Respiratory Medicine",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_17_OCR",
      "chapter": "**Pulmonary Edema**",
      "section": "PART 3 – Clinical Respiratory Medicine",
      "pageNumber": 31
    }
  },
  {
    "id": "fc_abg_b4d90f06",
    "front": "TSC2-deficient tumors respond to?",
    "back": "Anti-PD-1 / anti-CTLA-4 immunotherapy.",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Arterial Blood Gas Interpretation",
    "bookId": "abg",
    "sourceSection": "PART 3 – Clinical Respiratory Medicine",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_17_OCR",
      "chapter": "**Pulmonary Edema**",
      "section": "PART 3 – Clinical Respiratory Medicine",
      "pageNumber": 31
    }
  },
  {
    "id": "fc_abg_78da6348",
    "front": "PD-L1 upregulated in what lung disease?",
    "back": "Pulmonary lymphangioleiomyomatosis (LAM).",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Arterial Blood Gas Interpretation",
    "bookId": "abg",
    "sourceSection": "PART 3 – Clinical Respiratory Medicine",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_17_OCR",
      "chapter": "**Pulmonary Edema**",
      "section": "PART 3 – Clinical Respiratory Medicine",
      "pageNumber": 31
    }
  },
  {
    "id": "fc_abg_a91757d9",
    "front": "TSC2-deficient tumors exhibit what T-cell state?",
    "back": "T cell exhaustion.",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Arterial Blood Gas Interpretation",
    "bookId": "abg",
    "sourceSection": "PART 3 – Clinical Respiratory Medicine",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_17_OCR",
      "chapter": "**Pulmonary Edema**",
      "section": "PART 3 – Clinical Respiratory Medicine",
      "pageNumber": 31
    }
  },
  {
    "id": "fc_abg_14793601",
    "front": "LAM often caused by mutations in?",
    "back": "TSC2 gene.",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Arterial Blood Gas Interpretation",
    "bookId": "abg",
    "sourceSection": "PART 3 – Clinical Respiratory Medicine",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_17_OCR",
      "chapter": "**Pulmonary Edema**",
      "section": "PART 3 – Clinical Respiratory Medicine",
      "pageNumber": 31
    }
  },
  {
    "id": "fc_abg_23ba8ac8",
    "front": "TSC1/TSC2 tumor suppressors regulate what pathway?",
    "back": "mTOR pathway.",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Arterial Blood Gas Interpretation",
    "bookId": "abg",
    "sourceSection": "PART 3 – Clinical Respiratory Medicine",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_17_OCR",
      "chapter": "**Pulmonary Edema**",
      "section": "PART 3 – Clinical Respiratory Medicine",
      "pageNumber": 31
    }
  },
  {
    "id": "fc_abg_e84e4975",
    "front": "TSC2-deficient tumors: immunotherapy response?",
    "back": "Respond to anti-PD-1/CTLA-4 due to T cell exhaustion.",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Arterial Blood Gas Interpretation",
    "bookId": "abg",
    "sourceSection": "PART 3 – Clinical Respiratory Medicine",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_17_OCR",
      "chapter": "**Pulmonary Edema**",
      "section": "PART 3 – Clinical Respiratory Medicine",
      "pageNumber": 31
    }
  },
  {
    "id": "fc_abg_8f5b5a70",
    "front": "PD-L1 upregulated in what lung disease?",
    "back": "Pulmonary Lymphangioleiomyomatosis (LAM).",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Arterial Blood Gas Interpretation",
    "bookId": "abg",
    "sourceSection": "PART 3 – Clinical Respiratory Medicine",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_17_OCR",
      "chapter": "**Pulmonary Edema**",
      "section": "PART 3 – Clinical Respiratory Medicine",
      "pageNumber": 31
    }
  },
  {
    "id": "fc_abg_17b05c8f",
    "front": "Sporadic pulmonary LAM caused by mutation?",
    "back": "TSC2 gene.",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Arterial Blood Gas Interpretation",
    "bookId": "abg",
    "sourceSection": "PART 3 – Clinical Respiratory Medicine",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_17_OCR",
      "chapter": "**Pulmonary Edema**",
      "section": "PART 3 – Clinical Respiratory Medicine",
      "pageNumber": 31
    }
  },
  {
    "id": "fc_abg_d8d4ed35",
    "front": "TSC1/TSC2 inhibit which critical pathway?",
    "back": "mTORC1 signaling pathway.",
    "difficulty": "easy",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Arterial Blood Gas Interpretation",
    "bookId": "abg",
    "sourceSection": "PART 3 – Clinical Respiratory Medicine",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_17_OCR",
      "chapter": "**Pulmonary Edema**",
      "section": "PART 3 – Clinical Respiratory Medicine",
      "pageNumber": 31
    }
  },
  {
    "id": "fc_abg_9264c364",
    "front": "TSC2-deficient tumors: T cell status?",
    "back": "Evidence of T cell exhaustion.",
    "difficulty": "moderate",
    "cardType": "definition",
    "conceptTags": [],
    "topic": "Arterial Blood Gas Interpretation",
    "bookId": "abg",
    "sourceSection": "PART 3 – Clinical Respiratory Medicine",
    "sourceLocation": {
      "bookName": "MurrayNadel_Section_17_OCR",
      "chapter": "**Pulmonary Edema**",
      "section": "PART 3 – Clinical Respiratory Medicine",
      "pageNumber": 31
    }
  }
]